Evidence map›Paper›PMID 39467679›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2024

[Clinical features and prognosis of children with fungal bloodstream infection following chemotherapy for acute leukemia].

Kai-Zhi Weng, Chun-Ping Wu, Shu-Quan Zhuang, Shu-Xian Huang, Xiao-Fang Wang, Yong-Zhi Zheng

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai-Zhi WengDepartment of Pediatric Hematology, Fujian Medical University Union Hospital/Fujian Institute of Hematology/Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
Chun-Ping Wu
Shu-Quan Zhuang
Shu-Xian HuangDepartment of Pediatric Hematology, Fujian Medical University Union Hospital/Fujian Institute of Hematology/Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.
Xiao-Fang Wang
Yong-Zhi Zheng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the clinical features and prognosis of children with fungal bloodstream infection (BSI) following chemotherapy for acute leukemia (AL).

methodsA retrospective analysis was performed on 23 children with fungal BSI following chemotherapy for AL in three hospitals in Fujian Province, China, from January 2015 to December 2023. Their clinical features and prognosis were analyzed.

resultsAmong all children following chemotherapy for AL, the incidence rate of fungal BSI was 1.38% (23/1 668). At the time of fungal BSI, 87% (20/23) of the children had neutrophil deficiency for more than one week, and all the children presented with fever, while 22% (5/23) of them experienced septic shock. All 23 children exhibited significant increases in C-reactive protein and procalcitonin levels. A total of 23 fungal isolates were detected in peripheral blood cultures, with

conclusionsFungal BSI following chemotherapy in children with AL often occurs in children with persistent neutrophil deficiency and lacks specific clinical manifestations. The children with fungal BSI following chemotherapy for AL experience a prolonged course of antifungal therapy and have a high mortality rate, with

Indexed as

LeukemiaAdolescentAntifungal AgentsChildChild, PreschoolFemaleHumansInfantMaleMycosesPrognosisRetrospective StudiesAntifungal AgentsAcute leukemiaAntifungal therapyBloodstream infectionChildInvasive fungal diseasePrognosis

Identifiers

PMID39467679
PMCPMC11527414

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.